VARIANTS DE L'ALPHA-ANTITRYSPINE HUMAINE GLYCOSYLEE ET PROCEDE POUR LA PREPARATION

A viral expression vector of alpha1-AT or of a variant of alpha1-AT, chosen from: [AA ]alpha1-AT, [AA ]alpha1-AT[AA ,AA ]alpha1-AT and the corresponding variants of the truncated form [delta 1->5]alpha1-AT and [delta 1->5]alpha1-AT, characterised in that it consists of a hybrid virus of the va...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	TIM SKFRN, SOPHIE JALLAT ET MICHAEL COURTNEY
Format:	Patent
Sprache:	fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A viral expression vector of alpha1-AT or of a variant of alpha1-AT, chosen from: [AA ]alpha1-AT, [AA ]alpha1-AT[AA ,AA ]alpha1-AT and the corresponding variants of the truncated form [delta 1->5]alpha1-AT and [delta 1->5]alpha1-AT, characterised in that it consists of a hybrid virus of the vaccine which contains a DNA sequence coding for the said variant of alpha1-AT inserted into a nonessential part of the virus genome and under the control of an expression sequence which is effective in the vaccine.